December 8, 2025Blood

Lipid metabolism disorders and immune metabolic programming in patients with idiopathic multicentric Castleman disease

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Analysis reveals serum cholesterol correlates with disease severity in patients with Castleman disease, suggesting potential prognostic markers.

Cholesterol metabolism showed significant alterations in patients with idiopathic multicentric Castleman disease, impacting immune functions.
Serum cholesterol levels were significantly reduced, with lower total cholesterol linked to worse progression-free survival outcomes.
Proteomic analysis highlighted depletion of lipid transport proteins in iMCD patients compared to healthy donors and impairment in related pathways.
Findings indicate a potential interaction between immune responses and lipid metabolism, suggesting new avenues for understanding disease progression.

Jianping Ge (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Analysis reveals serum cholesterol correlates with disease severity in patients with Castleman disease, suggesting potential prognostic markers.